RBBP6
Basic information
Region (hg38): 16:24537693-24572863
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RBBP6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 81 | 89 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 82 | 16 | 0 |
Variants in RBBP6
This is a list of pathogenic ClinVar variants found in the RBBP6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-24546178-A-G | not specified | Uncertain significance (Mar 06, 2023) | ||
16-24548961-G-A | not specified | Uncertain significance (Jun 02, 2023) | ||
16-24553544-C-T | not specified | Uncertain significance (Feb 21, 2024) | ||
16-24553558-G-GTA | not specified | Likely benign (Dec 16, 2022) | ||
16-24555699-A-G | not specified | Uncertain significance (Mar 03, 2022) | ||
16-24555713-T-C | not specified | Likely benign (Jun 07, 2021) | ||
16-24555813-CC-TT | not specified | Uncertain significance (Jun 13, 2022) | ||
16-24555887-A-C | not specified | Likely benign (Mar 01, 2022) | ||
16-24559542-T-C | not specified | Uncertain significance (Oct 05, 2023) | ||
16-24561643-G-C | not specified | Likely benign (Feb 06, 2023) | ||
16-24561840-A-G | not specified | Uncertain significance (Jun 30, 2023) | ||
16-24561871-A-G | not specified | Likely benign (Jul 28, 2022) | ||
16-24561909-C-T | not specified | Uncertain significance (Dec 20, 2022) | ||
16-24561959-T-C | not specified | Uncertain significance (Oct 22, 2021) | ||
16-24561981-T-C | not specified | Uncertain significance (Aug 17, 2021) | ||
16-24562016-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
16-24562022-A-G | not specified | Uncertain significance (May 18, 2023) | ||
16-24562045-G-C | not specified | Uncertain significance (Sep 22, 2022) | ||
16-24562046-T-G | not specified | Uncertain significance (Sep 22, 2022) | ||
16-24562068-C-T | not specified | Uncertain significance (Jul 25, 2023) | ||
16-24562083-C-T | not specified | Uncertain significance (Aug 22, 2022) | ||
16-24562094-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
16-24562160-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
16-24563274-T-G | not specified | Uncertain significance (Feb 13, 2024) | ||
16-24563633-C-T | not specified | Uncertain significance (Jul 27, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RBBP6 | protein_coding | protein_coding | ENST00000319715 | 18 | 35171 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 8.78e-12 | 125740 | 0 | 6 | 125746 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.49 | 809 | 937 | 0.863 | 0.0000502 | 11707 |
Missense in Polyphen | 34 | 118.27 | 0.28747 | 1446 | ||
Synonymous | -1.52 | 367 | 332 | 1.11 | 0.0000174 | 3433 |
Loss of Function | 8.00 | 2 | 78.4 | 0.0255 | 0.00000490 | 1050 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000126 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000927 | 0.0000924 |
European (Non-Finnish) | 0.0000178 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which promotes ubiquitination of YBX1, leading to its degradation by the proteasome (PubMed:18851979). May play a role as a scaffold protein to promote the assembly of the p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated ubiquitination and degradation of p53/TP53; may function as negative regulator of p53/TP53, leading to both apoptosis and cell growth (By similarity). Regulates DNA-replication and the stability of chromosomal common fragile sites (CFSs) in a ZBTB38- and MCM10- dependent manner. Controls ZBTB38 protein stability and abundance via ubiquitination and proteasomal degradation, and ZBTB38 in turn negatively regulates the expression of MCM10 which plays an important role in DNA-replication (PubMed:24726359). {ECO:0000250|UniProtKB:P97868, ECO:0000269|PubMed:18851979, ECO:0000269|PubMed:24726359}.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- loftool
- 0.281
- rvis_EVS
- -2.12
- rvis_percentile_EVS
- 1.53
Haploinsufficiency Scores
- pHI
- 0.757
- hipred
- Y
- hipred_score
- 0.745
- ghis
- 0.678
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.753
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rbbp6
- Phenotype
- growth/size/body region phenotype; cellular phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- rbbp6
- Affected structure
- trunk
- Phenotype tag
- abnormal
- Phenotype quality
- necrotic
Gene ontology
- Biological process
- protein polyubiquitination;in utero embryonic development;DNA replication;regulation of DNA replication;mRNA processing;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus;multicellular organism growth;embryonic organ development;somite development
- Cellular component
- chromosome;nucleolus;centrosome;cytosol;nuclear speck;protein-containing complex
- Molecular function
- RNA binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;protein kinase binding;ubiquitin protein ligase activity